CytomX Therapeutics
Biopharmaceutical company developing targeted cancer therapies using Probody technology.
Company facts
- Founded
- 2008
- Employees
- 121
- Headquarters
- United States
- Type
- Public
- Listed
- NASDAQ: CTMX
Biopharmaceutical company developing targeted cancer therapies using Probody technology.
Company facts